Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18267
Country/Region: Haiti
Year: 2017
Main Partner: Partners in Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $6,900,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $619,226
Care: Orphans and Vulnerable Children (HKID) $1,270,000
Care: TB/HIV (HVTB) $497,075
Care: Pediatric Care and Support (PDCS) $98,854
Strategic Information (HVSI) $150,099
Testing: HIV Testing and Counseling (HVCT) $922,948
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $502,399
Treatment: Adult Treatment (HTXS) $2,723,968
Treatment: Pediatric Treatment (PDTX) $115,431
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 65
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 8
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 66
GEND_GBV Number of people receiving post-GBV care 2018 74
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 118,704
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 3,633
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 2,422
HTS_TST Service Delivery Point by Agg Age (Community) Other: 15+, Female, Negative 2018 465
HTS_TST Service Delivery Point by Agg Age (Community) Other: 15+, Male, Negative 2018 309
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 12,149
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 8,100
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 200
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 133
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 8,147
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 5,431
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 24,170
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 16,113
HTS_TST Sum of Test Result disaggregates 2018 3,560
HTS_TST_POS By Test Result: Positive 2018 3,560
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 298
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 199
HTS_TST_POS Service Delivery Point by Agg Age (Community) Other: 15+, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point by Agg Age (Community) Other: 15+, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 358
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 238
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 87
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 57
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 803
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 535
OVC_SERV Age/Sex: <1 2018 480
OVC_SERV Age/Sex: 1-9 2018 1,920
OVC_SERV Age/Sex: 10-14 Female 2018 1,584
OVC_SERV Age/Sex: 10-14 Male 2018 1,056
OVC_SERV Age/Sex: 15-17 Female 2018 1,152
OVC_SERV Age/Sex: 15-17 Male 2018 767
OVC_SERV By: Age/sex: 18-24 Female 2018 863
OVC_SERV By: Age/sex: 25+ Female 2018 2,158
OVC_SERV By: Age/sex: Male 18-24 2018 577
OVC_SERV By: Age/sex: Male 25+ 2018 1,441
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 12,002
OVC_SERV Program Completion: Active 2018 8,713
OVC_SERV Program Completion: Exited without graduation 2018 443
OVC_SERV Program Completion: Graduation 2018 484
OVC_SERV Program Completion: Transferred 2018 2,362
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2018 10
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 25+ 2018 210
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2018 7
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 25+ 2018 140
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2018 166
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2018 53
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2018 4
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 25+ 2018 81
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 18-24 2018 2
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 25+ 2018 54
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 18-24 2018 86
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 25+ 2018 108
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 18-24 2018 38
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 25+ 2018 48
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2018 296
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2018 137
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2018 14
OVC_SERV Sum of Age/Sex disaggregates 2018 4,559
PMTCT_ART Already on ART at beginning of current pregnancy 2018 376
PMTCT_ART New on ART 2018 487
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 863
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 33,907
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 867
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 376
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 452
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 24
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 15
PMTCT_STAT By Age (Numerator): Unknown Age 2018 893
PMTCT_STAT By Number of known positives: Unknown Age 2018 398
PMTCT_STAT By Number of new negative: Unknown Age 2018 32,997
PMTCT_STAT By Number of new positives: Unknown Age 2018 511
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 33,907
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 34,957
PP_PREV Age/sex: 10-14 Female 2018 704
PP_PREV Age/sex: 15-19 Female 2018 513
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 1,220
PP_PREV Sum of Age/Sex disaggregates 2018 1,217
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 7
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 164
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 6
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 109
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 286
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 286
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 7
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 163
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 6
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 110
TB_PREV By Age/Sex (Numerator): <15, Female 2018 90
TB_PREV By Age/Sex (Numerator): <15, Male 2018 60
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 1,802
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,053
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 3,006
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 3,340
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 101
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 68
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 2,003
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,168
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 50
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,085
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 33
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 724
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,892
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,936
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 50
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,112
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 33
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 741
TX_CURR Aggregated Age/Sex: <15 Female 2018 402
TX_CURR Aggregated Age/Sex: <15 Male 2018 268
TX_CURR Aggregated Age/Sex: 15+ Female 2018 8,734
TX_CURR Aggregated Age/Sex: 15+ Male 2018 5,822
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 15,226
TX_CURR Sum of Aggregated Age/Sex <15 2018 670
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 14,556
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 15,226
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 68
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 68
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 1,932
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,350
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,419
TX_NEW Pregnancy status 2018 487
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 3,418
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 15,229
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 11,416
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 306
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 34
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 207
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 25
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 6,164
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 684
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 3,594
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 399
TX_PVLS Numerator: Indication: Routine 2018 10,274
TX_PVLS Numerator: Indication: Targeted 2018 1,142
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 767
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 412
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 44
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 274
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 30
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 8,222
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 913
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 4,798
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 532
TX_PVLS_den Denominator: Indication: Routine 2018 13,705
TX_PVLS_den Denominator: Indication: Targeted 2018 1,523
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 767
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 89
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 60
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,483
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 983
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 2,615
TX_RET Numerator by Status: Pregnant 2018 428
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 3,340
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 101
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 68
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,003
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,168
TX_RET_den Denominator by Status: Pregnant 2018 428
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 13,316
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 263
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 3
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 8
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 158
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 93
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 400
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 266
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 7,988
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 4,660
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 1,332
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 1,332
TX_TB_den Denominator: By Screen Result: Negative 2018 12,911
TX_TB_den Denominator: By Screen Result: Positive 2018 405
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 2,665
Cross Cutting Budget Categories and Known Amounts Total: $568,675
Gender: Gender Based Violence (GBV) $50,000
GBV Prevention
Motor Vehicles: Purchased $168,675
Human Resources for Health $350,000